Biological fuel cell and methods
A fuel cell has an anode and a cathode with anode enzyme disposed on the anode and cathode enzyme is disposed on the cathode. The anode is configured and arranged to electrooxidize an anode reductant in the presence of the anode enzyme. Likewise, the cathode is configured and arranged to electroreduce a cathode oxidant in the presence of the cathode enzyme. In addition, anode redox hydrogel may be disposed on the anode to transduce a current between the anode and the anode enzyme and cathode redox hydrogel may be disposed on the cathode to transduce a current between the cathode and the cathode enzyme.
1. An electrochemical cell for generating electrical power in a biological system comprising oxygen, comprising:
a substrate comprising a first face and a second face;
an anode disposed on the first face of the substrate, wherein the anode comprises an anode enzyme;
a cathode disposed on the second face of the substrate, wherein the cathode comprises platinum; and
a mass transport limiting membrane disposed over the anode and the cathode,
wherein at least one of the anode and the cathode comprises a mediator chemically bonded to a polymer.
2. The electrochemical cell according to claim 1 , wherein the anode enzyme is a glucose-responsive enzyme.
3. The electrochemical cell according to claim 2 , wherein the glucose-responsive enzyme is glucose oxidase or glucose dehydrogenase.
4. The electrochemical cell according to claim 2 , wherein the glucose-responsive enzyme further comprises an enzyme cofactor.
5. The electrochemical cell according to claim 4 , wherein the enzyme cofactor is pyrroloquinoline quinone (PQQ).
6. The electrochemical cell according to claim 1 , wherein the cathode further comprises a cathode enzyme.
7. The electrochemical cell according to claim 6 , wherein the cathode enzyme is laccase or cytochrome C.
8. The electrochemical cell according claim 1 , wherein the mediator comprises a transition metal complex.
9. The electrochemical cell according claim 8 , wherein the transition metal complex comprises ruthenium or osmium.
10. The electrochemical cell according claim 1 , wherein the polymer comprises at least one heterocyclic nitrogen-containing moiety selected from the group consisting of pyridine, imidazole, oxazole, thiazole, pyrazole, and any derivative thereof.
11. The electrochemical cell according claim 10 , wherein the polymer comprises at least one heterocyclic nitrogen-containing moiety selected from the group consisting of 2-vinylpyridine, 3-vinylpyridine, 4-vinylpyridine, 1-vinylimidazole, 2-vinylimidazole and 4-vinylimidazole.
12. The electrochemical cell according claim 1 , wherein the mediator is covalently bonded to the polymer.
13. The electrochemical cell according claim 12 , wherein the mediator forms one or more of carbon-carbon, carbon-nitrogen, or metal-carbon covalent bonds with the polymer.
14. The electrochemical cell according claim 12 , wherein the mediator is covalently bonded to the polymer through one or more ligands of the mediator.
15. The electrochemical cell according claim 14 , wherein the one or more ligands comprises a substituted or unsubstituted heterocyclic nitrogen-containing moiety.
16. The electrochemical cell according claim 12 , wherein one or more ligands of the mediator are substituents of the polymer backbone.
17. The electrochemical cell according claim 9 , wherein the polymer is crosslinked.
18. The electrochemical cell according claim 17 , wherein the mediator is crosslinked with the polymer.
19. The electrochemical cell according to claim 18 , wherein one or more ligands of the mediator are crosslinkers of the polymer.
20. The electrochemical cell according to claim 9 , wherein the polymer forms a coordination complex with the mediator.
21. The electrochemical cell according to claim 1 , wherein at least a portion of the electrochemical cell is configured to be subcutaneously positioned in a subject.